Mayo Clinic preparing to Commence Phase II FDA clinical trial for the treatment of COVID-19 with Vicromax™ Nasdaq:BSGM

Press/Media: Expert Comment

PeriodApr 16 2020

Media coverage

1

Media coverage

  • TitleMayo Clinic preparing to Commence Phase II FDA clinical trial for the treatment of COVID-19 with Vicromax™ Nasdaq:BSGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date4/16/20
    PersonsCheng Huang